Latest journal
All journals
March 2022
Myelodysplastic syndromes (MDS) are a rare group of blood disorders that can result in symptoms spanning from fatigue to easy bruising and bleeding. Based on a symposium that was part of the International Congress on Myelodysplastic Syndromes by the MDS Foundation, this article provides an overview of MDS.
Latest articles
All articles
This CME-accredited presidential debate-style discussion explores the topic of biosimilars within haematology and o… twitter.com/i/web/status/1…
Posted 19 May
This literature review was conducted with the aim to understand how β-thalassaemia affects patients’ lives in vario… twitter.com/i/web/status/1…
Posted 10 May
In this episode, we delve into some of the key insights provided by our guests, as well as other notable conversati… twitter.com/i/web/status/1…
Posted 26 April
We are pleased to announce @EMJReviews has been awarded the Queen’s Award for Enterprise for International Trade. F… twitter.com/i/web/status/1…
Posted 21 April
This podcast explores the latest advancements in gene therapy for the treatment of haemophilia, including what the… twitter.com/i/web/status/1…
Posted 19 April
Latest abstracts
All abstracts
Hepcidin, the Main Regulator of Iron Homeostasis, is a Marker of COVID-19 Severity and Mortality in a Cohort of Hospitalised Italian Patients
Hepcidin, the liver peptide hormone that regulates plasma iron concentration by blocking ferroportin function,4 is at the crossroad between iron metabolism and inflammation, being positively regulated by iron itself and proinflammatory cytokines,5 and may represent the link between iron deficiency and COVID-19 severity.
Read More